We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLT icon
826
Commault Systems
CVLT
$4.88B
$7.93M 0.02%
134,242
+49,443
+58% +$2.92M
TRN icon
827
Trinity Industries
TRN
$2.49B
$7.93M 0.02%
385,170
+5,901
+2% +$136K
SAIC icon
828
Saic
SAIC
$4.95B
$7.91M 0.02%
124,222
+51,063
+70% +$3.56M
EVR icon
829
Evercore
EVR
$12.4B
$7.91M 0.02%
110,519
+26,569
+32% +$2.18M
MD icon
830
Pediatrix Medical
MD
$2.18B
$7.9M 0.02%
239,523
+67,867
+40% +$2.73M
LEG icon
831
Leggett & Platt
LEG
$1.34B
$7.9M 0.02%
220,428
-2,489
-1% -$94.7K
LHCG
832
DELISTED
LHC Group LLC
LHCG
$7.89M 0.02%
84,102
+15,125
+22% +$1.45M
MTZ icon
833
MasTec
MTZ
$21.1B
$7.86M 0.02%
193,858
+127,642
+193% +$5.5M
BOH icon
834
Bank of Hawaii
BOH
$3.15B
$7.85M 0.02%
116,648
+35,843
+44% +$2.73M
OZK icon
835
Bank OZK
OZK
$5.6B
$7.85M 0.02%
343,816
+75,252
+28% +$2.09M
CADE
836
DELISTED
Cadence Bank
CADE
$7.83M 0.02%
299,547
+107,999
+56% +$3.14M
SPR
837
DELISTED
Spirit AeroSystems
SPR
$7.82M 0.02%
108,498
-6,852
-6% -$556K
CCMP
838
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$7.8M 0.02%
81,849
+21,747
+36% +$2.13M
FLR icon
839
Fluor
FLR
$7.01B
$7.8M 0.02%
242,344
+5,365
+2% +$231K
SRCL
840
DELISTED
Stericycle Inc
SRCL
$7.8M 0.02%
212,677
+70,840
+50% +$3.33M
RRX icon
841
Regal Rexnord
RRX
$13.7B
$7.8M 0.02%
111,354
+36,796
+49% +$2.78M
STMP
842
DELISTED
Stamps.com, Inc.
STMP
$7.79M 0.02%
50,039
+9,013
+22% +$1.6M
EXAS
843
DELISTED
Exact Sciences
EXAS
$7.78M 0.02%
123,289
-5,763
-4% -$396K
SXT icon
844
Sensient Technologies
SXT
$5.26B
$7.77M 0.02%
139,120
+51,507
+59% +$3.37M
HBI
845
DELISTED
Hanesbrands
HBI
$7.74M 0.02%
618,016
-25,229
-4% -$393K
MOG.A icon
846
Moog Inc Class A
MOG.A
$12.4B
$7.71M 0.02%
99,578
+16,180
+19% +$1.28M
VYX icon
847
NCR Voyix
VYX
$1.14B
$7.71M 0.02%
544,174
+139,696
+35% +$2.19M
GLPI icon
848
Gaming and Leisure Properties
GLPI
$12.7B
$7.7M 0.02%
238,349
-373
-0.2% -$12.6K
FHI icon
849
Federated Hermes
FHI
$4.55B
$7.7M 0.02%
289,871
+106,477
+58% +$2.65M
AWR icon
850
American States Water
AWR
$3.36B
$7.69M 0.02%
114,761
+17,093
+18% +$1.1M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.